Serody JS - Search Results

1

BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.

Zaiken MC, Flynn R, Paz KG, Rhee SY, Jin S, Mohamed FA, Saha A, Thangavelu G, Park PMC, Hemming ML, Sage PT, Sharpe AH, DuPage M, Bluestone JA, Panoskaltsis-Mortari A, Cutler CS, Koreth J, Antin JH, Soiffer RJ, Ritz J, Luznik L, Maillard I, Hill GR, MacDonald KPA, Munn DH, Serody JS, Murphy WJ, Kean LS, Zhang Y, Bradner JE, Qi J, Blazar BR. Zaiken MC, et al. Among authors: serody js. Blood. 2022 May 12;139(19):2983-2997. doi: 10.1182/blood.2021014557. Blood. 2022. PMID: 35226736 Free PMC article.

2

Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.

Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Serody JS, et al. Blood. 1999 Jan 1;93(1):43-50. Blood. 1999. PMID: 9864144 Free article.

3

T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.

Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, Lira SA, Cook DN, Blazar BR. Serody JS, et al. Blood. 2000 Nov 1;96(9):2973-80. Blood. 2000. PMID: 11049973 Free article.

4

Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice.

Panoskaltsis-Mortari A, Hermanson JR, Taras E, Wangensteen OD, Serody JS, Blazar BR. Panoskaltsis-Mortari A, et al. Among authors: serody js. Blood. 2003 May 1;101(9):3714-21. doi: 10.1182/blood-2002-08-2465. Epub 2003 Jan 2. Blood. 2003. PMID: 12511416 Free article.

5

In vivo imaging of graft-versus-host-disease in mice.

Panoskaltsis-Mortari A, Price A, Hermanson JR, Taras E, Lees C, Serody JS, Blazar BR. Panoskaltsis-Mortari A, et al. Among authors: serody js. Blood. 2004 May 1;103(9):3590-8. doi: 10.1182/blood-2003-08-2827. Epub 2004 Jan 8. Blood. 2004. PMID: 14715632 Free article.

6

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Sun K, Welniak LA, Panoskaltsis-Mortari A, O'Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ. Sun K, et al. Among authors: serody js. Proc Natl Acad Sci U S A. 2004 May 25;101(21):8120-5. doi: 10.1073/pnas.0401563101. Epub 2004 May 17. Proc Natl Acad Sci U S A. 2004. PMID: 15148407 Free PMC article.

7

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells.

Sauer MG, Ericson ME, Weigel BJ, Herron MJ, Panoskaltsis-Mortari A, Kren BT, Levine BL, Serody JS, June CH, Taylor PA, Blazar BR. Sauer MG, et al. Among authors: serody js. Cancer Res. 2004 Jun 1;64(11):3914-21. doi: 10.1158/0008-5472.CAN-03-3991. Cancer Res. 2004. PMID: 15173002

8

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.

Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS. Wysocki CA, et al. Among authors: serody js. J Immunol. 2004 Jul 15;173(2):845-54. doi: 10.4049/jimmunol.173.2.845. J Immunol. 2004. PMID: 15240671

9

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL, June CH, Serody JS, Blazar BR. Taylor PA, et al. Among authors: serody js. Blood. 2004 Dec 1;104(12):3804-12. doi: 10.1182/blood-2004-05-1850. Epub 2004 Aug 3. Blood. 2004. PMID: 15292057 Free article.

10

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.

Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA. Blazar BR, et al. Among authors: serody js. J Immunol. 2004 Sep 1;173(5):2933-41. doi: 10.4049/jimmunol.173.5.2933. J Immunol. 2004. PMID: 15322151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page